AVM v1, released 02-OCT-22

A manually curated database of aerosol-transmitted virus mutations, human diseases, and drugs

Mutation detail:


Mutation site Y1321N
Virus Human respiratory syncytial virus
Mutation level Amino acid Level
Gene/protein/region type L
Gene ID 1494467
Country -
Mutation type nonsynonymous mutation
Genotype/subtype/clade -
Sample cell line
Variants -
Viral reference sequence M74568.1
Drug/antibody/vaccine -
Transmissibility -
Transmission mechanism -
Pathogenicity -
Pathogenicity mechanism -
Immune escape mutation -
Immune escape mechanism -
RT-PCR primers probes -

Protein detail:


Protein name Polymerase
Uniprot protein ID P28887
Protein length 2165 amino acids
Protein description The core polymerase in RSV is composed of two proteins, a 250 kDa polymerase subunit (L), which contains the RNA-dependent RNA polymerase, the polyribonucleotidyl transferase (PRNTase, capping), and the methyltransferase enzymatic domains essential for viral transcription and replication, and the 27 kDa phosphoprotein (P) accessory protein. . The L protein caps mRNA by a unique RNA-GDP polyribonucleotidyl transferase activity mapped to conserved region V (CRV). Methylation of the cap at the guanine-N-7 and ribose-2-O positions is catalyzed by a unique dual specificity methyltransferase activity that has been functionally mapped to region VI of the L protein.

Literature information:


Pubmed ID 23236065
Clinical information No
Disease -
Published year 2013
Journal Journal of virology
Title Respiratory Syncytial Virus Modified by Deletions of the NS2 Gene and Amino Acid S1313 of the L Polymerase Protein Is a Temperature-Sensitive, Live-Attenuated Vaccine Candidate That Is Phenotypically Stable at Physiological Temperature
Author Cindy Luongo,Christine C. Winter,Peter L. Collins,Ursula J. Buchholz
Evidence However, only 44% of infants developed a detectable serum IgA antibody response to RSV, raising some concern about immunogenicity. In addition, approximately one-third of the vaccine virus isolates recovered from vaccinees exhibited partial loss of the ph